04 Apr, EOD - Indian

SENSEX 75364.69 (-1.22)

Nifty 50 22904.45 (-1.49)

Nifty Bank 51502.7 (-0.18)

Nifty IT 33511.4 (-3.58)

Nifty Midcap 100 50645.95 (-2.91)

Nifty Next 50 61468.7 (-2.59)

Nifty Pharma 20560 (-4.03)

Nifty Smallcap 100 15675.95 (-3.56)

04 Apr, EOD - Global

NIKKEI 225 33780.58 (-2.75)

HANG SENG 22849.81 (-1.52)

S&P 5108.75 (-6.17)

LOGIN HERE

companylogoValiant Organics Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 540145 | NSE Symbol : VALIANTORG | ISIN : INE565V01010 | Industry : Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
25-Mar-2025 25-Mar-2025 Bonus Issue Please find our intimation in captioned subject
06-Feb-2025 13-Feb-2025 Quarterly Results Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve financial results for the quarter ended December 31 2024. The unaudited Standalone and Consolidated Financial results of the Company for the Quarter ended December 31, 2024 Outcome of Board Meeting (As per BSE Announcement Dated on 13/02/2025)
07-Nov-2024 13-Nov-2024 Quarterly Results Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Please find our intimation in captioned subject. Approval of financial results for the quarter and half year ended September 30, 2024 (As per BSE Announcement Dated on 13/11/2024)
06-Aug-2024 13-Aug-2024 Quarterly Results Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Please find our intimation in the captioned subject. Please find our intimation on the captioned subject. (As per BSE Announcement dated on 13/08/2024)
16-May-2024 24-May-2024 Accounts Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 inter alia to consider and approve Please find our intimation on the captioned subject Please find our intimation on the captioned subject. (As Per BSE Announcement dated on 24.05.2024)
05-Feb-2024 13-Feb-2024 Quarterly Results Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve The Audited Standalone & Consolidated Financial results of the Company for the Quarter ended December 31 2023 and Any other Business matter if required with the permission of Chair. Outcome of Board Meeting held today i.e., Tuesday, February 13, 2024. Financial Results for the quarter ended December 31,2023 (As Per BSE Announcement Dated on 13/02/2024)
31-Oct-2023 08-Nov-2023 Quarterly Results Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve The Audited Standalone & Consolidated Financial results of the Company for the Quarter and Half Year ended September 30 2023 and any other Business matter if required with the permission of Chair. Outcome of Board Meeting held on November 08, 2023. Audited Financial Results for Quarter and half year ended September 30, 2023. (As Per BSE Announcement Dated on 08/11/2023)
01-Aug-2023 09-Aug-2023 Quarterly Results Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve The Audited Standalone & Consolidated Financial results of the Company for the Quarter ended June 30 2023 and any other Business matter if required with the permission of Chair. Outcome of Board Meeting held today i.e., Wednesday, August 09, 2023. Results-Financial Results for June 30, 2023 (As Per BSE Announcement Dated on 09.08.2023)
11-May-2023 19-May-2023 Quarterly Results Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2023 inter alia to consider and approve 1. The Audited Standalone & Consolidated Financial results of the Company for the Quarter and financial year ended March 31 2023. 2. Any other Business matter if required with the permission of Chair. Outcome of Board Meeting held on May 19,2023 (As Per BSE Announcement Dated on 19.05.2023) Appointment of Dr. Sudhirprakash B. Sawant (DIN: 02343218) as Additional Director in the Category of Non-Executive Independent Director the Company. Reappointment of Auditors of the Company (As Per BSE Announcement Dated on 20.05.2023)
23-Jan-2023 31-Jan-2023 Quarterly Results Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 inter alia to consider and approve 1. The Audited Standalone & Consolidated Financial results of the Company for the Quarter and nine months ended December 31 2022. 2. Consider and declare the Interim Dividend if any for the financial year 2022-2023. 3. Any other Business matter if required with the permission of Chair. Board the Board of Directors of the Company has declared the Interim Dividend of Rs. 1/- (10%) per Equity share of Rs. 10/- each for the financial year 2022-23 (As Per BSE Bulletin Dated on 31.01.2023) Outcome of Board Meeting Declaration of Interim Dividend for the financial year 2022-23 Proposed Initial Public Offering of equity Shares by the Company''s material subsidiary, Valiant Laboratories Limited. (As Per BSE Announcement Dated on 31.01.2023)
01-Nov-2022 08-Nov-2022 Quarterly Results Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2022 inter alia to consider and approve 1. The Audited Standalone & Consolidated Financial results of the Company for the Quarter and Half Year ended September 30 2022. 2. Any other Business matter if required with the permission of Chair. Outcome of Board Meeting held on November 08,2022 (As Per BSE Announcement Dated on 08.11.2022) Newspaper Publication. (As Per BSE Announcement Dated on 09/11/2022)
27-Jul-2022 04-Aug-2022 Quarterly Results Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2022 inter alia to consider and approve Audited Standalone & Consolidated Financial results of the Company for the Quarter ended June 30 2022 and Any other Business matter if required with the permission of Chair. Newspaper Publication of Financial Results. (As Per BSE Announcement Dated on 06/08/2022) Outcome of Board Meeting held on August 04,2022 (As Per BSE Announcement Dated 04.08.2022)
17-May-2022 25-May-2022 Accounts Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2022 inter alia to consider and approve the Audited Standalone & Consolidated Financial Results of the Company for the Quarter and year ended March 31 2022 and any other Business matter if any. The Board Meeting to be held on 24/05/2022 has been revised to 25/05/2022 The Board Meeting to be held on 24/05/2022 has been rescheduled to 25/05/2022. (As Per BSE Announcement Dated on 20.05.2022) Outcome of Board Meeting The Board of Directors have recommended a final Dividend of Rs.3.5/- (Three Rupees and Fifty paisa Only) per equity share i.e., 35% for the Financial Year ended March 31,2022, subject to the approval of Shareholders of the Company at the ensuing Annual General Meeting. The final dividend would be paid within 30 days from the date of declaration at the Annual General Meeting. Outcome of Board Meeting (As Per BSE Announcement Dated on 25/05/2022)
30-Apr-2022 30-Apr-2022 Change in Directors Outcome of Board Meeting held on April 30,2022
29-Jan-2022 07-Feb-2022 Quarterly Results Valiant Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2022 inter alia to consider and approve The Audited Standalone & Consolidated Financial results of the Company for the Quarter and nine months ended December 31 2021 and any other Business matter if required with the permission of Chair. Outcome of Board Meeting held on Monday , February 07,2022 for approval of Audited Financial Results for Quarter and Nine Months ended December 31,2021 Audited Financial Results for the Quarter and Nine Months ended December 31,2021 (As Per BSE Announcement dated on 07.02.2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +